FutureFuel Third Quarter Net Income of
$9.4 Million
FutureFuel Corp. (NYSE:FF) (“FutureFuel”), a manufacturer of custom
and performance chemicals and biofuels, today announced financial
results for the third quarter and the nine months ended September
30, 2018.
Third Quarter 2018 Financial Highlights (all
comparisons are with the third quarter of 2017)
- Revenues were $81.4 million, up 4.9% from $77.6 million
- Adjusted EBITDA was $13.7 million, up 43.0% from $9.6
million
- Net income increased to $9.4 million, or $0.22 per diluted
share, from $3.3 million, or $0.08 per diluted share.
Nine Month 2018 Financial Highlights (all
comparisons are with the first nine months of 2017)
- Revenues were $225.5 million, up 12.9% from $199.8 million
- EBITDA was $62.9 million, up 265.8% from $17.2 million
- Net income increased to $51.3 million, or $1.17 per diluted
share, from $7.6 million, or $0.17 per diluted share.
“We saw strong demand across the board for our products and
services in the third quarter. Combined with our solid operational
performance, we were able to realize continued year on year growth
in both our chemical and biodiesel segments. As we approach the end
of the year, we remain in limbo with regard to reinstatement of the
Blenders Tax Credit for 2018 and forward into 2019. Our entire
industry would benefit from certainty over this issue,” said Tom
McKinlay, Chief Operating Officer for FutureFuel Corp.
2018 Regular Cash Dividends
FutureFuel paid a normal quarterly dividend of $0.06 per share
in the third quarter of 2018. The remaining quarterly
dividends of $0.06 per share will be paid in December.
Financial Overview and Key Operating
Metrics
Financial and operating metrics, which include non-GAAP
financial measures, include dollars in thousands, except per share
amounts:
FutureFuel Corp.Certain
Financial and Operating Metrics(Unaudited)
|
Three months ended September 30, |
|
|
|
|
|
Dollar |
|
% |
|
2018 |
|
2017 |
|
Change |
|
Change |
Revenues |
$ |
81,422 |
|
$ |
77,606 |
|
$ |
3,816 |
|
|
4.9 |
% |
Income from
operations |
$ |
10,229 |
|
$ |
3,200 |
|
$ |
7,029 |
|
|
219.7 |
% |
Net income |
$ |
9,445 |
|
$ |
3,334 |
|
$ |
6,111 |
|
|
183.3 |
% |
Earnings per common
share: |
|
|
|
|
|
|
|
Basic |
$ |
0.22 |
|
$ |
0.08 |
|
$ |
0.14 |
|
|
175.0 |
% |
Diluted |
$ |
0.22 |
|
$ |
0.08 |
|
$ |
0.14 |
|
|
175.0 |
% |
Capital expenditures
and intangibles (net of customer reimbursements and regulatory
grants) |
$ |
642 |
|
$ |
856 |
|
$ |
(214 |
) |
|
(25.0 |
%) |
Adjusted EBITDA |
$ |
13,661 |
|
$ |
9,553 |
|
$ |
4,108 |
|
|
43.0 |
% |
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
|
|
|
|
|
Dollar |
|
% |
|
2018 |
|
2017 |
|
Change |
|
Change |
Revenues |
$ |
225,505 |
|
$ |
199,765 |
|
$ |
25,740 |
|
|
12.9 |
% |
Income from
operations |
$ |
50,636 |
|
$ |
6,049 |
|
$ |
44,587 |
|
|
737.1 |
% |
Net income |
$ |
51,322 |
|
$ |
7,564 |
|
$ |
43,758 |
|
|
578.5 |
% |
Earnings per common
share: |
|
|
|
|
|
|
|
Basic |
$ |
1.17 |
|
$ |
0.17 |
|
$ |
1.00 |
|
|
588.2 |
% |
Diluted |
$ |
1.17 |
|
$ |
0.17 |
|
$ |
1.00 |
|
|
588.2 |
% |
Capital expenditures
and intangibles (net of customer reimbursements and regulatory
grants) |
$ |
1,539 |
|
$ |
2,413 |
|
$ |
(874 |
) |
|
(36.2 |
%) |
Adjusted EBITDA |
$ |
62,926 |
|
$ |
17,201 |
|
$ |
45,725 |
|
|
265.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial and Business
Summary
Consolidated sales revenue in the three and nine
months ended September 30, 2018 increased 4.9% or $3,816 and
12.9% or $25,740, compared to the three and nine months ended
September 30, 2017. The current three-month period was benefited
$6,086 from higher biofuel prices and unfavorably affected by a
volume reduction in pipeline trades. In the first nine
months, sales revenue benefited from strong demand in the Ag
chemical and energy markets with higher sales volumes and prices in
both segments. Within the chemical segment, sales
volume/product mix improved 11.0% or $8,543 in addition to an
increase of $2,212 from higher average selling prices. The
price increases were primarily from higher prices indexed to higher
raw material prices. Within the biofuel segment, sales
revenue increased $9,745 in the nine-month period from improved
sales volumes and product mix and $5,240 from higher average
selling prices experienced in the fuel industry. Negatively
influencing this price effect was the retroactive reinstatement of
the 2017 blenders’ tax credit (BTC) passed into law on February 9,
2018. Gross profit in the three and nine months
ended September 30, 2018 increased $7,127 and $44,977 compared
to the three months and nine months ended September 30, 2017.
The three-month increase was primarily from stronger margins in the
biofuel segment. The nine-month increase was primarily from
improved margins in the biofuel segment from the BTC which expired
on December 31, 2016 and was retroactively reinstated
for 2017 (but, not beyond 2017)
on February 9, 2018 resulting in the benefit being recognized
in 2018. Also benefiting gross profit in the nine-month period
was increased sales volumes in both the chemicals and biofuels
segments.
Gross profit was additionally benefited in the
three and nine months ended September 30, 2018, as compared to the
prior year period, by the adjustment in the carrying value of our
inventory as determined utilizing the LIFO method of inventory
accounting. The change in this adjustment decreased gross
profit $443 in the three months ended September 30, 2018 and
increased gross profit $2,708 in the nine months ended
September 30, 2018 as compared to the three and nine months ended
September 30, 2017. This LIFO adjustment did not result in a
lower of cost or market adjustment in the three and nine months
ended September 30, 2018 and 2017. Please see Note 3
for additional discussion.
Lastly, gross profit was favorably impacted by
the change in the unrealized and realized activity in derivative
instruments with a loss of $676 in the three months ended September
30, 2018, as compared to a loss of $3,314 in the prior year
period. In the nine-month period, gross profit was impacted
negatively by the change in unrealized and realized activity in
derivative instruments with a loss of $3,947, as compared to a loss
of $1,511, in the prior year period.
Net Income
Net income for the three and nine
months ended September 30, 2018 increased $6,111 and $43,758
as compared to the same periods in
2017. The increase was from stronger sales volumes, a 14%
reduction in the federal statutory tax rate, and biodiesel tax
credits and incentives that were reinstated in the three months
ended March 31, 2018 that were not in effect for 2017.
Capital Expenditures
Capital expenditures and intangibles were $3,084 in the first
nine months of 2018, compared with $2,614 in the same period in
2017. FutureFuel was reimbursed for a portion of these expenditures
by certain customers as summarized in the following table.
|
Nine months ended September 30, |
|
2018 |
|
2017 |
Cash paid for capital
expenditures and intangibles |
$ |
3,084 |
|
|
$ |
2,614 |
|
Cash received as
reimbursement of capital expenditures |
$ |
(1,545 |
) |
|
$ |
(201 |
) |
Cash paid, net of
reimbursement, for capital expenditures |
$ |
1,539 |
|
|
$ |
2,413 |
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents and Marketable
Securities
Cash and cash equivalents and marketable
securities totaled $302,450 as of September 30, 2018, compared with
$235,326 as of December 31, 2017.
About FutureFuel
FutureFuel is a leading manufacturer of
diversified chemical products, specialty chemical products, and
biofuel products. In its chemicals business, FutureFuel
manufactures specialty chemicals for specific customers (“custom
chemicals”) as well as multi-customer specialty chemicals
(“performance chemicals”). FutureFuel’s custom chemicals product
portfolio includes a bleach activator for a major detergent
manufacturer, proprietary herbicide and intermediates for major
life sciences companies, and chlorinated polyolefin adhesion
promoters and antioxidant precursors for a major chemical company.
FutureFuel’s performance chemicals product portfolio includes
polymer (nylon) modifiers and several small-volume specialty
chemicals for diverse applications. FutureFuel’s biofuels segment
primarily produces and sells biodiesel to its customers. Please
visit www.futurefuelcorporation.com for more information.
Forward-Looking Statements
This document contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements deal with
FutureFuel’s current plans, intentions, beliefs, and
expectations, and statements of future economic performance.
Statements containing such terms as “believe,” “do not believe,”
“plan,” “expect,” “intend,” “estimate,” “anticipate,” and other
phrases of similar meaning are considered to contain uncertainty
and are forward-looking statements. In addition, from time to time
FutureFuel or its representatives have made or will make
forward-looking statements orally or in writing. Furthermore, such
forward-looking statements may be included in various filings that
the company makes with United States Securities and Exchange
Commission (the “SEC”), in press releases, or in oral statements
made by or with the approval of one of FutureFuel’s authorized
executive officers.
These forward-looking statements are subject to
certain known and unknown risks and uncertainties, as
well as assumptions that could cause actual results to differ
materially from those reflected in these forward-looking
statements. Factors that might cause actual results to differ
include, but are not limited to, those set forth under the headings
“Risk Factors” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” in FutureFuel’s Form
10-K Annual Report for the year ended December 31, 2017 and in its
future filings made with the SEC. An investor should not place
undue reliance on any forward-looking statements contained in this
document, which reflect FutureFuel management’s opinions only as of
their respective dates. Except as required by law, the company
undertakes no obligation to revise or publicly release the results
of any revisions to forward-looking statements. The risks and
uncertainties described in this document and in current and future
filings with the SEC are not the only ones faced by FutureFuel. New
factors emerge from time to time, and it is not possible for the
company to predict which will arise. There may be additional risks
not presently known to the company or that the company currently
believes are immaterial to its business. In addition, FutureFuel
cannot assess the impact of each factor on its business or the
extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking statements. If any such risks occur, FutureFuel’s
business, operating results, liquidity, and financial condition
could be materially affected in an adverse manner. An investor
should consult any additional disclosures FutureFuel has made or
will make in its reports to the SEC on Forms 10-K, 10-Q, and 8-K,
and any amendments thereto. All subsequent written and oral
forward-looking statements attributable to FutureFuel or persons
acting on its behalf are expressly qualified in their entirety by
the cautionary statements contained in this document.
Non-GAAP Financial Measures
In this press release, FutureFuel used adjusted
EBITDA as a key operating metric to measure both performance and
liquidity. Adjusted EBITDA is a non-GAAP financial measure.
Adjusted EBITDA is not a substitute for operating income, net
income, or cash flow from operating activities (each as determined
in accordance with GAAP), as a measure of performance or liquidity.
Adjusted EBITDA has limitations as an analytical tool, and should
not be considered in isolation or as a substitute for analysis of
results as reported under GAAP. FutureFuel defines adjusted EBITDA
as net income before interest, income taxes, depreciation, and
amortization expenses, excluding, when applicable, non-cash
share-based compensation expense, public offering expenses,
acquisition-related transaction costs, purchase accounting
adjustments, loss on disposal of property and equipment, gains or
losses on derivative instruments, other non-operating income or
expense. Information relating to adjusted EBITDA is provided so
that investors have the same data that management
employs in assessing the overall operation and liquidity of
FutureFuel’s business. FutureFuel’s calculation of adjusted EBITDA
may be different from similarly titled measures used by other
companies; therefore, the results of its calculation are not
necessarily comparable to the results of other companies.
Adjusted EBITDA allows FutureFuel’s chief
operating decision makers to assess the performance and liquidity
of FutureFuel’s business on a consolidated basis to assess the
ability of its operating segments to produce operating cash flow to
fund working capital needs, to fund capital expenditures, and to
pay dividends. In particular, FutureFuel management believes that
adjusted EBITDA permits a comparative assessment of FutureFuel’s
operating performance and liquidity, relative to a performance and
liquidity based on GAAP results, while isolating the effects of
depreciation and amortization, which may vary among its operating
segments without any correlation to their underlying operating
performance, and of non-cash stock-based compensation expense,
which is a non-cash expense that varies widely among similar
companies, and gains and losses on derivative instruments, whose
immediate recognition can cause net income to be volatile from
quarter to quarter due to the timing of the valuation change in the
derivative instruments relative to the sale of biofuel.
A table included in this earnings release
reconciles adjusted EBITDA with net income, the most directly
comparable GAAP performance financial measure, and a table
reconciles adjusted EBITDA with cash flows from operations, the
most directly comparable GAAP liquidity financial measure.
FutureFuel
Corp.Condensed Consolidated Balance
Sheets(Dollars in
thousands)
|
(Unaudited) |
|
|
|
September 30, 2018 |
|
December 31, 2017 |
Assets |
|
|
|
Cash and cash
equivalents |
$ |
199,348 |
|
$ |
114,627 |
Accounts receivable,
net of allowances for bad debt of $0 and $0, at September 30, 2018
and December 31, 2017, respectively |
|
21,489 |
|
|
22,138 |
Inventory |
|
48,005 |
|
|
43,754 |
Marketable
securities |
|
103,102 |
|
|
120,699 |
Other current
assets |
|
1,782 |
|
|
9,140 |
Total current
assets |
|
373,726 |
|
|
310,358 |
Property, plant and
equipment, net |
|
104,254 |
|
|
109,735 |
Other assets |
|
5,225 |
|
|
5,470 |
Total noncurrent
assets |
|
109,479 |
|
|
115,205 |
Total
Assets |
$ |
483,205 |
|
$ |
425,563 |
Liabilities and
Stockholders’ Equity |
|
|
|
Accounts payable |
$ |
34,546 |
|
$ |
19,579 |
Dividends payable |
|
2,626 |
|
|
10,498 |
Other current
liabilities |
|
14,967 |
|
|
5,204 |
Total current
liabilities |
|
52,139 |
|
|
35,281 |
Deferred revenue –
long-term |
|
14,651 |
|
|
16,522 |
Other noncurrent
liabilities |
|
18,567 |
|
|
22,164 |
Total noncurrent
liabilities |
|
33,218 |
|
|
38,686 |
Total
liabilities |
|
85,357 |
|
|
73,967 |
Commitments and
contingencies: |
|
|
|
Preferred stock,
$0.0001 par value, 5,000,000 shares authorized, none issued and
outstanding |
|
- |
|
|
- |
Common stock, $0.0001
par value, 75,000,000 shares authorized, 43,743,243 and 43,741,670,
issued and outstanding as of September 30, 2018 and December 31,
2017, respectively |
|
4 |
|
|
4 |
Accumulated other
comprehensive income |
|
124 |
|
|
8,433 |
Additional paid in
capital |
|
282,109 |
|
|
281,964 |
Retained earnings |
|
115,611 |
|
|
61,195 |
Total
Stockholders’ Equity |
|
397,848 |
|
|
351,596 |
Total
Liabilities and Stockholders’ Equity |
$ |
483,205 |
|
$ |
425,563 |
|
|
|
|
|
|
FutureFuel
Corp.Condensed Consolidated Statements of
Operationsand Comprehensive
Income(Dollars in thousands, except per share
amounts)(Unaudited)
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Revenue |
$ |
81,422 |
|
|
$ |
77,606 |
|
|
$ |
225,505 |
|
|
$ |
199,765 |
|
Cost of goods sold and
distribution |
|
68,769 |
|
|
|
72,080 |
|
|
|
167,074 |
|
|
|
186,311 |
|
Gross profit |
|
12,653 |
|
|
|
5,526 |
|
|
|
58,431 |
|
|
|
13,454 |
|
Selling, general, and
administrative expenses |
|
1,547 |
|
|
|
1,391 |
|
|
|
4,952 |
|
|
|
4,870 |
|
Research and
development expenses |
|
877 |
|
|
|
935 |
|
|
|
2,843 |
|
|
|
2,535 |
|
|
|
2,424 |
|
|
|
2,326 |
|
|
|
7,795 |
|
|
|
7,405 |
|
Income from
operations |
|
10,229 |
|
|
|
3,200 |
|
|
|
50,636 |
|
|
|
6,049 |
|
Other income, net |
|
3,228 |
|
|
|
1,864 |
|
|
|
3,022 |
|
|
|
4,890 |
|
Income before income
taxes |
|
13,457 |
|
|
|
5,064 |
|
|
|
53,658 |
|
|
|
10,939 |
|
Provision for income
taxes |
|
4,012 |
|
|
|
1,730 |
|
|
|
2,336 |
|
|
|
3,375 |
|
Net income |
$ |
9,445 |
|
|
$ |
3,334 |
|
|
$ |
51,322 |
|
|
$ |
7,564 |
|
|
|
|
|
|
|
|
|
Earnings per common
share |
|
|
|
|
|
|
|
Basic |
$ |
0.22 |
|
|
$ |
0.08 |
|
|
$ |
1.17 |
|
|
$ |
0.17 |
|
Diluted |
$ |
0.22 |
|
|
$ |
0.08 |
|
|
$ |
1.17 |
|
|
$ |
0.17 |
|
Weighted average shares
outstanding |
|
|
|
|
|
|
|
Basic |
|
43,724,195 |
|
|
|
43,705,234 |
|
|
|
43,719,215 |
|
|
|
43,662,672 |
|
Diluted |
|
43,732,920 |
|
|
|
43,714,753 |
|
|
|
43,725,370 |
|
|
|
43,671,420 |
|
|
|
|
|
|
|
|
|
Comprehensive
Income |
|
|
|
|
|
|
|
Net income |
$ |
9,445 |
|
|
$ |
3,334 |
|
|
$ |
51,322 |
|
|
$ |
7,564 |
|
Other
comprehensive income from unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net gain
on available-for-sale securities |
|
(27 |
) |
|
|
1,006 |
|
|
|
(19 |
) |
|
|
7,102 |
|
Income
tax effect |
|
6 |
|
|
|
(353 |
) |
|
|
4 |
|
|
|
(2,490 |
) |
Total
unrealized (loss)/gain, net of tax |
|
(21 |
) |
|
|
653 |
|
|
|
(15 |
) |
|
|
4,612 |
|
Comprehensive income |
$ |
9,424 |
|
|
$ |
3,987 |
|
|
$ |
51,307 |
|
|
$ |
12,176 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FutureFuel
Corp.Consolidated Statements of Cash
FlowsFor the Nine Months Ended September 30, 2017
and 2016(Dollars in
thousands)(Unaudited)
|
Nine months ended September 30, |
|
2018 |
|
2017 |
Cash flows
provided by operating activities |
|
|
|
Net income |
$ |
51,322 |
|
|
$ |
7,564 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
Depreciation |
|
8,244 |
|
|
|
8,735 |
|
Amortization of deferred financing costs |
|
108 |
|
|
|
109 |
|
Benefit
for deferred income taxes |
|
(3,609 |
) |
|
|
(1,303 |
) |
Change in
fair value of equity securities |
|
5,597 |
|
|
|
- |
|
Change in
fair value of derivative instruments |
|
(2,290 |
) |
|
|
(60 |
) |
Other
than temporary impairment of marketable securities |
|
- |
|
|
|
177 |
|
Impairment of fixed assets |
|
258 |
|
|
|
28 |
|
(Gain)/loss on the sale of investments |
|
(2,324 |
) |
|
|
366 |
|
Stock
based compensation |
|
321 |
|
|
|
878 |
|
Loss on
disposal of fixed assets |
|
41 |
|
|
|
145 |
|
Noncash
interest expense |
|
22 |
|
|
|
20 |
|
Changes
in operating assets and liabilities: |
|
|
|
Accounts
receivable |
|
3,031 |
|
|
|
3,081 |
|
Accounts
receivable – related parties |
|
(2,382 |
) |
|
|
(1,181 |
) |
Inventory |
|
(4,251 |
) |
|
|
8,570 |
|
Income
tax receivable |
|
6,458 |
|
|
|
5,546 |
|
Prepaid
expenses |
|
1,190 |
|
|
|
1,152 |
|
Prepaid
expenses – related parties |
|
- |
|
|
|
(4 |
) |
Accrued
interest on marketable securities |
|
9 |
|
|
|
22 |
|
Other
assets |
|
(256 |
) |
|
|
37 |
|
Accounts
payable |
|
13,018 |
|
|
|
1,425 |
|
Accounts
payable – related parties |
|
1,949 |
|
|
|
2,780 |
|
Accrued
expenses and other current liabilities |
|
5,385 |
|
|
|
1,587 |
|
Accrued
expenses and other current liabilities – related parties |
|
- |
|
|
|
(142 |
) |
Deferred
revenue |
|
(2,672 |
) |
|
|
(3,220 |
) |
Other
noncurrent liabilities |
|
- |
|
|
|
128 |
|
Net cash provided by operating activities |
|
79,169 |
|
|
|
36,440 |
|
Cash flows from
investing activities |
|
|
|
Collateralization of derivative instruments |
|
2,384 |
|
|
|
(760 |
) |
Purchase
of marketable securities |
|
(19,664 |
) |
|
|
(25,795 |
) |
Proceeds
from the sale of marketable securities |
|
33,942 |
|
|
|
14,913 |
|
Proceeds
from the sale of fixed assets |
|
22 |
|
|
|
4 |
|
Capital
expenditures |
|
(3,084 |
) |
|
|
(2,614 |
) |
Net cash provided by/(used in) investing
activities |
|
13,600 |
|
|
|
(14,252 |
) |
Cash flows from
financing activities |
|
|
|
Minimum
tax withholding on stock options exercised and awards vested |
|
(176 |
) |
|
|
(121 |
) |
Excess
tax benefits associated with stock options and awards |
|
- |
|
|
|
(31 |
) |
Payment
of dividends |
|
(7,872 |
) |
|
|
(108,063 |
) |
Net cash used in financing activities |
|
(8,048 |
) |
|
|
(108,215 |
) |
Net change in cash and
cash equivalents |
|
84,721 |
|
|
|
(86,027 |
) |
Cash and cash
equivalents at beginning of period |
|
114,627 |
|
|
|
199,272 |
|
Cash and cash
equivalents at end of period |
$ |
199,348 |
|
|
$ |
113,245 |
|
|
|
|
|
Cash paid for
interest |
$ |
- |
|
|
$ |
- |
|
Cash paid for income
taxes |
$ |
1,506 |
|
|
$ |
55 |
|
|
|
|
|
|
|
|
|
FutureFuel
Corp.Reconciliation of Non-GAAP Financial Measure
to Financial Measure(Dollars in
thousands)(Unaudited)
Reconciliation of Adjusted EBITDA to Net
Income
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Adjusted EBITDA |
$ |
13,661 |
|
|
$ |
9,553 |
|
|
$ |
62,926 |
|
|
$ |
17,201 |
|
Depreciation |
|
(2,732 |
) |
|
|
(2,927 |
) |
|
|
(8,244 |
) |
|
|
(8,735 |
) |
Non-cash stock-based
compensation |
|
(107 |
) |
|
|
(128 |
) |
|
|
(321 |
) |
|
|
(878 |
) |
Interest and dividend
income |
|
2,543 |
|
|
|
1,965 |
|
|
|
6,688 |
|
|
|
5,679 |
|
Non-cash interest
expense (including amortization of deferred financing costs) |
|
(43 |
) |
|
|
(43 |
) |
|
|
(130 |
) |
|
|
(129 |
) |
Losses on disposal of
property and equipment |
|
(4 |
) |
|
|
(68 |
) |
|
|
(41 |
) |
|
|
(145 |
) |
Losses on derivative
instruments |
|
(676 |
) |
|
|
(3,314 |
) |
|
|
(3,947 |
) |
|
|
(1,511 |
) |
Gains/(losses) on
marketable securities |
|
815 |
|
|
|
26 |
|
|
|
(3,273 |
) |
|
|
(543 |
) |
Provision for income
taxes |
|
(4,012 |
) |
|
|
(1,730 |
) |
|
|
(2,336 |
) |
|
|
(3,375 |
) |
Net income |
$ |
9,445 |
|
|
$ |
3,334 |
|
|
$ |
51,322 |
|
|
$ |
7,564 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Adjusted EBITDA to Net Cash Provided
by Operating Activities
|
Nine months ended September 30, |
|
2018 |
|
2017 |
Adjusted EBITDA |
$ |
62,926 |
|
|
$ |
17,201 |
|
Benefit for deferred
income taxes |
|
(3,609 |
) |
|
|
(1,303 |
) |
Impairment of fixed
assets |
|
258 |
|
|
|
28 |
|
Interest and dividend
income |
|
6,688 |
|
|
|
5,679 |
|
Provision for income
taxes |
|
(2,336 |
) |
|
|
(3,375 |
) |
Losses on derivative
instruments |
|
(3,947 |
) |
|
|
(1,511 |
) |
Change in fair value of
derivative instruments |
|
(2,290 |
) |
|
|
(60 |
) |
Changes in operating
assets and liabilities, net |
|
21,479 |
|
|
|
19,781 |
|
Net cash provided by
operating activities |
$ |
79,169 |
|
|
$ |
36,440 |
|
|
|
|
|
|
|
|
|
FutureFuel
Corp.Condensed Consolidated Segment
Income(Dollars in
thousands)(Unaudited)
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Revenue |
|
|
|
|
|
|
|
Custom chemicals |
$ |
23,973 |
|
|
$ |
23,593 |
|
|
$ |
74,465 |
|
|
$ |
65,189 |
|
Performance chemicals |
|
4,049 |
|
|
|
4,574 |
|
|
|
14,165 |
|
|
|
12,686 |
|
Chemicals
revenue |
|
28,022 |
|
|
|
28,167 |
|
|
|
88,630 |
|
|
|
77,875 |
|
Biofuels
revenue |
|
53,400 |
|
|
|
49,439 |
|
|
|
136,875 |
|
|
|
121,890 |
|
Total Revenue |
$ |
81,422 |
|
|
$ |
77,606 |
|
|
$ |
225,505 |
|
|
$ |
199,765 |
|
|
|
|
|
|
|
|
|
Segment gross
profit/(loss) |
|
|
|
|
|
|
|
Chemicals |
$ |
8,898 |
|
|
$ |
8,060 |
|
|
$ |
24,470 |
|
|
$ |
20,401 |
|
Biofuels |
|
3,755 |
|
|
|
(2,534 |
) |
|
|
33,961 |
|
|
|
(6,947 |
) |
Total gross profit |
|
12,653 |
|
|
|
5,526 |
|
|
|
58,431 |
|
|
|
13,454 |
|
Corporate expenses |
|
(2,424 |
) |
|
|
(2,326 |
) |
|
|
(7,795 |
) |
|
|
(7,405 |
) |
Income before interest
and taxes |
|
10,229 |
|
|
|
3,200 |
|
|
|
50,636 |
|
|
|
6,049 |
|
Interest and other
income |
|
3,358 |
|
|
|
1,965 |
|
|
|
6,688 |
|
|
|
5,679 |
|
Interest and other
expense |
|
(130 |
) |
|
|
(101 |
) |
|
|
(3,666 |
) |
|
|
(789 |
) |
Provision for income
taxes |
|
(4,012 |
) |
|
|
(1,730 |
) |
|
|
(2,336 |
) |
|
|
(3,375 |
) |
Net income |
$ |
9,445 |
|
|
$ |
3,334 |
|
|
$ |
51,322 |
|
|
$ |
7,564 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation is allocated to segment costs of
goods sold based on plant usage. The total assets and capital
expenditures of FutureFuel have not been allocated to individual
segments as large portions of these assets are shared to varying
degrees by each segment, causing such an allocation to be of little
value.
COMPANY CONTACTFutureFuel Corp.Tom
McKinlay(314)854-8352www.futurefuelcorporation.com
FutureFuel (NYSE:FF)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
FutureFuel (NYSE:FF)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024